← Leaderboards
Steven Tiwen Chen
Icahn School Of Medicine At Mount Sinai
$188,720
Attributed
$188,720
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $51K · FY2019–22$100K$75K$50K$25K$0
'19
'20
'21
'22
Funding mix
By agency
NIH$188,720 · 1
By mechanism
F30$188,720 · 1
Top collaborators
No co-investigators on record.
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Amaia Lujambio$5,368,450
- Miriam Merad$28,468,631
- Darrell J Irvine$37,519,809
- Brian D Brown$18,622,393
- Andrew Sikora$5,297,462
Others in their field
Other Emerging Leaders on “Central Tolerance”
- Xinhua Li · Nano Terra, Inc.$11,962,715
- Christopher M Jewell · Baltimore Va Medical Center$5,329,097
- William H. Peranteau · Children'S Hosp Of Philadelphia$4,881,032
- Matthew Leoni · Cerevel Therapeutics, Llc$4,050,000
- Vera Hoffman · Reveal Pharma$4,050,000
- Philip Iredale · Cerevel Therapeutics, Llc$4,050,000
Research focus
Central ToleranceAntigen-Presenting CellsAffectAblationArchitectureAutoantigensAntigensBone MarrowBone Marrow TransplantationAntitumor ResponseCancer ImmunotherapyCancer ModelCancer TherapyCancer TypeCandidate Disease GeneCd 200Cd4 Positive T LymphocytesCd8b1 GeneCd8-Positive T-LymphocytesCell CommunicationCellsCell ShapeCellular BiologyChemokine
Grant awards (4)
Using CRISPR/Cas9 Pro-code technology to dissect the migratory dendritic cell signature$48,908
F30 · FY2022 · CA · contact PI
Using CRISPR/Cas9 Pro-code technology to dissect the migratory dendritic cell signature$51,036
F30 · FY2021 · CA · contact PI
Using CRISPR/Cas9 Pro-code technology to dissect the migratory dendritic cell signature$43,920
F30 · FY2020 · CA · contact PI
Using CRISPR/Cas9 Pro-code technology to dissect the migratory dendritic cell signature$44,856
F30 · FY2019 · CA · contact PI